Bondarenko Acquires 16.2% Beneficial Ownership of BriaCell Therapeutics Corp.
September 10, 2019 08:55 ET
|
Jamieson Bondarenko
TORONTO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 3,154,302 common shares (the “Shares”) of BriaCell Therapeutics...
Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell Therapeutics Corp.
May 17, 2019 09:24 ET
|
Jamieson Bondarenko
TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 1,698,000 common shares (the “Shares”) of BriaCell Therapeutics...
Jamieson Bondarenko Acquires 5,000,000 Common Shares of BriaCell Therapeutics Corp.
March 25, 2019 21:26 ET
|
Jamieson Bondarenko
TORONTO, March 25, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 5,000,000 common shares (the “Shares”) of BriaCell Therapeutics...
Jamieson Bondarenko Acquires 11.0% Beneficial Ownership of BriaCell Therapeutics Corp.
February 12, 2019 19:57 ET
|
Jamieson Bondarenko
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 2,000,000 common shares (the “Shares”) of BriaCell Therapeutics...